Work

Nanomedicine: Transforming the Management of Ocular Neuroinflammatory and Neurodegenerative Diseases

Year: 2025

Type: article

Abstract: Nanomedicine is emerging as a groundbreaking strategy for the management of the neuro-visual symptoms of neuroinflammatory and neurodegenerative diseases. This innovative field of study leverages nanoscale materials and technologies to improve drug delivery, enabling targeted treatments to reach the affected ocular tissues. By facilitating the transport of therapeutic agents across the blood–retinal barrier and boosting their bioavailability, nanomedicine holds the potential to significantly mitigate the symptoms of conditions such as Alzheimer’s disease (AD), Parkinson’s disease (PD), multiple sclerosis (MS), etc. This review summarizes the latest developments in nanomedicine applications for the management of these ocular conditions, highlighting their capacity to foster more effective disease diagnosis and treatment.

Source: Journal of Nanotheranostics

DOI: 10.3390/jnt6010006

Authors: Georgia Savvidou, Ellas Spyratou, Maria-Eleni Zachou, Efstathios P. Efstathopoulos

Institutions: National and Kapodistrian University of Athens, University General Hospital Attikon

Language: English

Topic: Advanced Drug Delivery Systems

Subfield: Pharmaceutical Science

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,207